Gongwin Biopharm Holdings Co., Ltd.(TW:6617)
NT$126.50+8.00 (+6.75%)
TW:6617
Gongwin Biopharm Holdings Co., Ltd. financials statements
NT$126.50
At close:+8.00 (+6.75%)
Gongwin Biopharm Holdings Co., Ltd. (6617) Ratios
Gongwin Biopharm Holdings Co., Ltd. Ratios
TW:6617's free cash flow for Q2 2026 was NT$-61.11M. For the 2026 fiscal year, TW:6617's free cash flow was decreased by NT$-1.51M and operating cash flow was NT$-59.60M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.36 | 13.36 | 8.86 | 6.99 | 5.95 |
| Quick Ratio | 10.35 | 13.34 | 8.76 | 6.99 | 5.95 |
| Cash Ratio | 5.37 | 4.90 | 2.17 | 3.51 | 2.93 |
| Solvency Ratio | -0.37 | -0.25 | -0.39 | -0.97 | -0.59 |
| Operating Cash Flow Ratio | -0.75 | -0.48 | -0.88 | -1.21 | -0.62 |
| Short-Term Operating Cash Flow Coverage | -1.16 | -0.79 | -1.48 | -1.73 | -0.84 |
| Net Current Asset Value | NT$ 1.59B | NT$ 2.15B | NT$ 915.52M | NT$ 1.09B | NT$ 735.69M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.04 | 0.05 | 0.09 | 0.10 |
| Debt-to-Equity Ratio | 0.05 | 0.04 | 0.06 | 0.10 | 0.12 |
| Debt-to-Capital Ratio | 0.05 | 0.04 | 0.06 | 0.09 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.11 | 1.09 | 1.15 | 1.17 | 1.21 |
| Debt Service Coverage Ratio | -1.60 | -0.66 | -0.99 | -1.73 | -1.01 |
| Interest Coverage Ratio | -40.17 | -37.67 | -18.55 | -90.72 | -96.22 |
| Debt to Market Cap | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.09 | 1.08 | 0.74 | 1.30 | 1.05 |
| Net Debt to EBITDA | 4.28 | 10.09 | 2.42 | 1.92 | 3.37 |
| Profitability Margins | |||||
| Gross Profit Margin | 41.12% | 27.09% | 59.21% | 93.26% | 94.31% |
| EBIT Margin | -568.76% | -273.26% | -496.89% | -25279.79% | -9933.51% |
| EBITDA Margin | -538.30% | -237.10% | -428.48% | -24108.66% | -8799.83% |
| Operating Profit Margin | -568.76% | -505.80% | -704.87% | -25279.79% | -9933.51% |
| Pretax Profit Margin | -331.64% | -286.69% | -534.89% | -25558.44% | -10036.75% |
| Net Profit Margin | -313.14% | -257.64% | -486.58% | -22238.76% | -10637.01% |
| Continuous Operations Profit Margin | -332.07% | -287.10% | -534.89% | -25558.44% | -11366.58% |
| Net Income Per EBT | 94.42% | 89.87% | 90.97% | 87.01% | 105.98% |
| EBT Per EBIT | 58.31% | 56.68% | 75.89% | 101.10% | 101.04% |
| Return on Assets (ROA) | -4.08% | -2.44% | -6.07% | -15.67% | -10.37% |
| Return on Equity (ROE) | -4.51% | -2.66% | -7.00% | -18.26% | -12.52% |
| Return on Capital Employed (ROCE) | -7.92% | -5.06% | -9.60% | -20.20% | -11.16% |
| Return on Invested Capital (ROIC) | -7.57% | -4.89% | -9.09% | -16.01% | -10.03% |
| Return on Tangible Assets | -4.08% | -2.44% | -6.07% | -15.67% | -10.37% |
| Earnings Yield | -1.07% | -0.60% | -0.45% | -0.73% | -0.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.47 | 1.22 | 1.25 | 0.27 | 20.78 |
| Payables Turnover | 165.08 | 112.85 | 26.88 | 0.00 | 0.00 |
| Inventory Turnover | 24.17 | 6.51 | 0.65 | 0.36 | 0.00 |
| Fixed Asset Turnover | 0.11 | 0.10 | 0.16 | 0.00 | 0.00 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 |
| Cash Conversion Cycle | 261.99 | 353.02 | 842.00 | 2356.73 | 17.56 |
| Days of Sales Outstanding | 249.10 | 300.23 | 291.31 | 1356.54 | 17.56 |
| Days of Inventory Outstanding | 15.10 | 56.03 | 564.27 | 1000.19 | 0.00 |
| Days of Payables Outstanding | 2.21 | 3.23 | 13.58 | 0.00 | 0.00 |
| Operating Cycle | 264.20 | 356.26 | 855.58 | 2356.73 | 17.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.10 | -0.72 | -0.98 | -2.09 | -0.86 |
| Free Cash Flow Per Share | -1.12 | -2.43 | -0.99 | -2.14 | -0.86 |
| Dividend Paid and CapEx Coverage Ratio | -55.25 | -0.42 | -122.29 | -37.62 | -1768.67 |
| Capital Expenditure Coverage Ratio | -55.25 | -0.42 | -122.29 | -37.62 | -1768.67 |
| Operating Cash Flow Coverage Ratio | -1.05 | -0.69 | -1.44 | -1.64 | -0.83 |
| Operating Cash Flow to Sales Ratio | -3.72 | -2.73 | -5.86 | -203.15 | -83.56 |
| Free Cash Flow Yield | -1.30% | -2.14% | -0.54% | -0.69% | -0.31% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -93.59 | -166.91 | -225.31 | -136.03 | -252.01 |
| Price-to-Sales (P/S) Ratio | 291.59 | 427.89 | 1092.87 | 30287.17 | 26887.19 |
| Price-to-Book (P/B) Ratio | 4.20 | 4.41 | 15.71 | 24.87 | 31.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -76.89 | -46.71 | -184.69 | -145.23 | -321.59 |
| Price-to-Operating Cash Flow Ratio | -78.28 | -156.85 | -186.57 | -149.09 | -321.77 |
| Price-to-Earnings Growth (PEG) Ratio | -2.65 | 10.40 | 3.49 | -1.26 | -10.08 |
| Enterprise Value Multiple | -49.89 | -170.37 | -252.63 | -123.71 | -302.17 |
| Enterprise Value | 9.79B | 12.94B | 20.48B | 34.09B | 30.39B |
| EV to EBITDA | -49.89 | -170.37 | -252.63 | -123.71 | -302.17 |
| EV to Sales | 268.57 | 403.96 | 1082.48 | 29823.68 | 26590.61 |
| EV to Free Cash Flow | -70.82 | -44.09 | -182.93 | -143.01 | -318.05 |
| EV to Operating Cash Flow | -72.10 | -148.08 | -184.80 | -146.81 | -318.23 |
| Tangible Book Value Per Share | 20.39 | 25.66 | 11.58 | 12.36 | 8.91 |
| Shareholders’ Equity Per Share | 20.51 | 25.72 | 11.61 | 12.52 | 8.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | 0.00 | 0.13 | -0.13 |
| Revenue Per Share | 0.30 | 0.27 | 0.17 | 0.01 | 0.01 |
| Net Income Per Share | -0.92 | -0.68 | -0.81 | -2.29 | -1.10 |
| Tax Burden | 0.94 | 0.90 | 0.91 | 0.87 | 1.06 |
| Interest Burden | 0.58 | 1.05 | 1.08 | 1.01 | 1.01 |
| Research & Development to Revenue | 3.28 | 1.97 | 2.78 | 170.01 | 72.66 |
| SG&A to Revenue | 3.17 | 3.17 | 4.86 | 58.99 | 33.99 |
| Stock-Based Compensation to Revenue | 0.00 | 0.29 | 0.00 | 25.62 | 0.50 |
| Income Quality | 1.12 | 0.95 | 1.10 | 0.79 | 0.83 |
Currency in TWD
